AMRX
Amneal Pharmaceuticals, Inc.
Amneal Pharmaceuticals, Inc. (AMRX) has 9 SEC Form 4 filings (9 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: May 12, 2026.
Insiders have net sold $451K over the trailing 6 months.
- Industry:Drug Manufacturers - Specialty & Generic
- CEO:Chirag K. Patel
- Employees:8,500
- HQ:Bridgewater, NJ, US
- IPO:2018-05-07
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$451K
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$5.9B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Autor Deborah M.First filing | Director | Sale | 34,819 | $451K | May 12 | SEC ↗ |
Related companies
Amneal Pharmaceuticals, Inc. is in the Healthcare sector.